Authors

Minesh Mehta, Baptist Health Medical Group; Miami Cancer InstituteFollow

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial

Publication Date

4-1-2024

Content Type

Article

PubMed ID:

37506981

Additional Authors:

Additional authors and institutional affiliations

Citation

Kim, I. A., Winter, K. A., Sperduto, P. W., De Los Santos, J. F., Peereboom, D. M., Ogunleye, T., Boulter, D., Fritz, J. M., Cho, K. H., Shin, K. H., Zoberi, I., Choi, S., Palmer, J. D., Liem, B., Kim, Y. B., Anderson, B. M., Thakrar, A. W., Muanza, T. M., Kim, M. M., Choi, D. H., … White, J. R. (2024). Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial. International journal of radiation oncology, biology, physics, 118(5), 1391–1401. https://doi.org/10.1016/j.ijrobp.2023.07.019